Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
John Celebi | PRESIDENT AND CEO | 2025-02-19 | 5,558 | $0.48 | $2.65kSell |
Der Horst Edward Van | CHIEF SCIENTIFIC OFFICER | 2025-02-19 | 2,276 | $0.48 | $1.08kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
James Peyer | 700.99% | 8,841,457 | $76.74M | Insider |
Hs Investments I LP | 350.91% | 4,425,998 | $38.42M | Insider |
Cambrian Biopharma Inc | 289.63% | 3,653,120 | $31.71M | Insider |
Thomas G. Ricks | 54.36% | 685,632 | $5.95M | Insider |
John Celebi | 8.39% | 105,862 | $918.88k | Insider |
Robert Hamilton Pierce | 7.49% | 94,463 | $819.94k | Insider |
Erin Colgan | 5.35% | 67,462 | $585.57k | Insider |
Der Horst Edward Van | 4.74% | 59,794 | $519.01k | Insider |
Patrick Stephen Gallagher | 2.71% | 34,130 | $296.25k | Insider |
Vanguard Group Inc | 2.31% | 29,090 | $252.50k | Institution |